Drug Type Universal CAR-T |
Synonyms Universal GPC3-CAR-T cell(Wondercel Biotech) |
Target |
Action modulators |
Mechanism GPC3 modulators(Glypican-3 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseSuspendedEarly Phase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Hepatocellular Carcinoma | Phase 1 | China | 23 Oct 2024 | |
| Advanced Lung Non-Small Cell Carcinoma | Phase 1 | China | 23 Oct 2024 |





